美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA204770"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
50090-3670-0 50090-3670 HUMAN PRESCRIPTION DRUG Metaxalone Metaxalone TABLET ORAL 20181016 N/A ANDA ANDA204770 A-S Medication Solutions METAXALONE 800 mg/1 20 TABLET in 1 BOTTLE (50090-3670-0)
60760-289-06 60760-289 HUMAN PRESCRIPTION DRUG Metaxalone Metaxalone TABLET ORAL 20200616 N/A ANDA ANDA204770 St. Mary's Medical Park Pharmacy METAXALONE 800 mg/1 6 TABLET in 1 BOTTLE, PLASTIC (60760-289-06)
60760-289-20 60760-289 HUMAN PRESCRIPTION DRUG Metaxalone Metaxalone TABLET ORAL 20200331 N/A ANDA ANDA204770 St. Mary's Medical Park Pharmacy METAXALONE 800 mg/1 20 TABLET in 1 BOTTLE, PLASTIC (60760-289-20)
60760-289-30 60760-289 HUMAN PRESCRIPTION DRUG Metaxalone Metaxalone TABLET ORAL 20200331 N/A ANDA ANDA204770 St. Mary's Medical Park Pharmacy METAXALONE 800 mg/1 30 TABLET in 1 BOTTLE, PLASTIC (60760-289-30)
60760-289-60 60760-289 HUMAN PRESCRIPTION DRUG Metaxalone Metaxalone TABLET ORAL 20200424 N/A ANDA ANDA204770 St. Mary's Medical Park Pharmacy METAXALONE 800 mg/1 60 TABLET in 1 BOTTLE, PLASTIC (60760-289-60)
60760-289-90 60760-289 HUMAN PRESCRIPTION DRUG Metaxalone Metaxalone TABLET ORAL 20200331 N/A ANDA ANDA204770 St. Mary's Medical Park Pharmacy METAXALONE 800 mg/1 90 TABLET in 1 BOTTLE, PLASTIC (60760-289-90)
51655-792-20 51655-792 HUMAN PRESCRIPTION DRUG Metaxalone Metaxalone TABLET ORAL 20220120 N/A ANDA ANDA204770 Northwind Health Company, LLC METAXALONE 800 mg/1 20 TABLET in 1 BOTTLE, PLASTIC (51655-792-20)
51655-792-52 51655-792 HUMAN PRESCRIPTION DRUG Metaxalone Metaxalone TABLET ORAL 20220120 N/A ANDA ANDA204770 Northwind Health Company, LLC METAXALONE 800 mg/1 30 TABLET in 1 BOTTLE, PLASTIC (51655-792-52)
51655-792-53 51655-792 HUMAN PRESCRIPTION DRUG Metaxalone Metaxalone TABLET ORAL 20220120 N/A ANDA ANDA204770 Northwind Health Company, LLC METAXALONE 800 mg/1 10 TABLET in 1 BOTTLE, PLASTIC (51655-792-53)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2026 Drugfuture->U.S. FDA National Drug Code DataBase